Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

Daniel Gaudet, Gerald F. Watts, Jennifer G. Robinson, Pascal Minini, William J. Sasiela, Jay Edelberg, Michael J. Louie, Frederick J. Raal

    Research output: Contribution to journal › Article › peer-review

    112 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science